Nasdaq · Healthcare
InMode Ltd. (INMD)
As-reported financials and recent SEC filings for InMode Ltd., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$370.5M
Net income
$93.8M
Net margin
25.3%
Diluted EPS
$1.43
ROE
13.7%
P/E (TTM)
10.8×
Market cap
$840.9M
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $370.5M | $394.8M | $492.0M | $454.3M | $357.6M |
| Gross profit | $291.0M | $317.1M | $411.3M | $380.8M | $304.0M |
| Operating income | $85.4M | $112.5M | $195.7M | $197.9M | $167.5M |
| Net income | $93.8M | $181.3M | $197.9M | $161.5M | $165.1M |
| Diluted EPS | $1.43 | $2.25 | $2.30 | $1.89 | $1.92 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
6-K2026-06-25
View on EDGAR →SCHEDULE 13D/A2026-06-24
View on EDGAR →6-K2026-06-24
View on EDGAR →6-K2026-06-18
View on EDGAR →32026-05-26
View on EDGAR →32026-05-26
View on EDGAR →6-K2026-05-20
View on EDGAR →6-K2026-05-06
View on EDGAR →Go deeper on INMD
Search InMode Ltd.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.